Concepedia

Herve Aloysius

HA

7

Publications

334

Citations

7

H-Index

2011

Active since

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Dassault Systèmes (United States)

Herve Aloysius is an author at Rutgers, The State University of New Jersey specializing in pharmacology, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

2011–2021

7

Publications

7

Enzyme-mediated hydrolytic activation of prodrugs

Yanhui Yang, Herve Aloysius, Daigo Inoyama et al. · Acta Pharmaceutica Sinica B · 2011 · 159 citations · Full text

TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations

Brion W. Murray, Dayong Zhai, Wei Deng et al. · Molecular Cancer Therapeutics · 2021 · 84 citations · Full text

<scp>l</scp>-Cystine Diamides as <scp>l</scp>-Cystine Crystallization Inhibitors for Cystinuria

Longqin Hu, Yanhui Yang, Herve Aloysius et al. · Journal of Medicinal Chemistry · 2016 · 31 citations

, , +9

Design, synthesis, and evaluation of l-cystine diamides as l-cystine crystallization inhibitors for cystinuria

Yanhui Yang, Haifa Albanyan, Sumi Lee et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 23 citations

, , +6

Metabolic Activation and Major Protein Target of a 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonist

Herve Aloysius, Vincent Tong, Jocelyn Yabut et al. · Chemical Research in Toxicology · 2012 · 16 citations

, , +21

Rows per page

1–5 of 7